Of course the ChatGPT dog cancer vaccine spawned a startup

Australian entrepreneur Paul Conyngham, who previously used ChatGPT and other AI tools to design a personalized mRNA cancer vaccine for his dog, has now launched a startup called Gamgee. The company aims to commercialize this approach, offering individualized mRNA-based cancer vaccines for dogs. While the concept builds on emerging veterinary oncology research, the use of generative AI in drug design raises questions about validation, regulatory pathways, and scalability. Gamgee’s launch highlights a growing trend where AI accelerates early-stage biotech innovation — particularly in niche markets like pet health — but also underscores the need for rigorous scientific oversight as AI moves from idea generation to real-world medical applications.